Page 94 - AN-1-1

Advanced Neurology TRPM2 in neurological disorders

100. Ko SY, Wang SE, Lee HK, et al., 2019, Transient receptor Genet B Neuropsychiatr Genet, 141B(1): 36–43.
potential melastatin 2 governs stress-induced depressive- https://doi.org/10.1002/ajmg.b.30239
like behaviors. Proc Natl Acad Sci U S A, 116(5): 1770–1775.
111. van Enkhuizen J, Minassian A, Young JW, 2013, Further
https://doi.org/10.1073/pnas.1814335116
evidence for ClockΔ19 mice as a model for bipolar
101. Akpinar A, Uğuz AC, Nazıroğlu M, 2014, Agomelatine and disorder mania using cross-species tests of exploration and
duloxetine synergistically modulates apoptotic pathway by sensorimotor gating. Behav Brain Res, 249: 44–54. https://
inhibiting oxidative stress triggered intracellular calcium doi.org/10.1016/j.bbr.2013.04.023
entry in neuronal PC12 cells: Role of TRPM2 and voltage- 112. van Enkhuizen J, Henry BL, Minassian A, et al., 2014,
gated calcium channels. J Membr Biol, 247(5): 451–459. Reduced dopamine transporter functioning induces high-
https://doi.org/10.1007/s00232-014-9652-1 reward risk-preference consistent with bipolar disorder.
Neuropsychopharmacology, 39(13): 3112–3122.
102. Anderson IM, Haddad PM, Scott J, 2012, Bipolar disorder.
BMJ, 345: e8508. https://doi.org/10.1038/npp.2014.170
https://doi.org/10.1136/bmj.e8508 113. Young JW, Cope ZA, Romoli B, et al., 2018, Mice with reduced
DAT levels recreate seasonal-induced switching between
103. Goldberg JF, Perlis RH, Bowden CL, et al., 2009, Manic states in bipolar disorder. Neuropsychopharmacology, 43(8):
symptoms during depressive episodes in 1,380 patients 1721–1731.
with bipolar disorder: Findings from the STEP-BD. Am J
Psychiatry, 166(2): 173–181. https://doi.org/10.1038/s41386-018-0031-y
https://doi.org/10.1176/appi.ajp.2008.08050746 114. Sonntag KC, Brenhouse HC, Freund N, et al., 2014, Viral over-
expression of D1 dopamine receptors in the prefrontal cortex
104. Merikangas KR, Jin R, He JP, et al., 2011, Prevalence and increase high-risk behaviors in adults: Comparison with
correlates of bipolar spectrum disorder in the world mental adolescents. Psychopharmacology (Berl), 231(8): 1615–1626.
health survey initiative. Arch Gen Psychiatry, 68(3): 241–251.
https://doi.org/10.1007/s00213-013-3399-8
https://doi.org/10.1001/archgenpsychiatry.2011.12
115. Borison RL, Sabelli HC, Maple PJ, et al., 1978, Lithium
105. Sullivan PF, Daly MJ, O’Donovan M, 2012, Genetic prevention of amphetamine-induced “manic” excitement
architectures of psychiatric disorders: The emerging picture and of reserpine-induced “depression” in mice: Possible role
and its implications. Nat Rev Genet, 13(8): 537–551. of 2-phenylethylamine. Psychopharmacology (Berl), 59(3):
https://doi.org/10.1038/nrg3240 259–262.
106. Berk M, Dodd S, Kauer-Sant’anna M, et al., 2007, Dopamine https://doi.org/10.1007/BF00426631
dysregulation syndrome: Implications for a dopamine hypothesis 116. Rezin GT, Furlanetto CB, Scaini G, et al., 2014,
of bipolar disorder. Acta Psychiatr Scand Suppl, 434: 41–49. Fenproporex increases locomotor activity and alters
https://doi.org/10.1111/j.1600-0447.2007.01058.x energy metabolism, and mood stabilizers reverse these
changes: A proposal for a new animal model of mania.
107. Rao JS, Harry GJ, Rapoport SI, et al., Increased excitotoxicity Mol Neurobiol, 49(2): 877–892.
and neuroinflammatory markers in postmortem frontal
cortex from bipolar disorder patients. Mol Psychiatry, 15(4): https://doi.org/10.1007/s12035-013-8566-8
384–392. 117. Markou A, Koob GF, 1991, Postcocaine anhedonia. An animal
https://doi.org/10.1038/mp.2009.47 model of cocaine withdrawal. Neuropsychopharmacology,
4(1): 17–26.
108. Andreazza AC, Wang JF, Salmasi F, et al., 2013, Specific
subcellular changes in oxidative stress in prefrontal cortex 118. Harrison PJ, Cipriani A, Harmer CJ, et al., 2016, Innovative
from patients with bipolar disorder. J Neurochem, 127(4): approaches to bipolar disorder and its treatment. Ann N Y
552–561. Acad Sci, 1366(1): 76–89.
https://doi.org/10.1111/jnc.12316 https://doi.org/10.1111/nyas.13048
109. Berk M, Kapczinski F, Andreazza AC, et al., 2011, pathways 119. Freund N, Juckel G, 2019, Bipolar disorder: Its etiology and
underlying neuroprogression in bipolar disorder: Focus on how to model in rodents. Methods Mol Biol, 2011: 61–77.
inflammation, oxidative stress and neurotrophic factors. https://doi.org/10.1007/978-1-4939-9554-7_4
Neurosci Biobehav Rev, 35(3): 804–817.
120. Kostyrko A, Hauser J, Rybakowski JK, et al., 2006, Screening
https://doi.org/10.1016/j.neubiorev.2010.10.001 of chromosomal region 21q22.3 for mutations in genes
associated with neuronal Ca signalling in bipolar affective
2+
110. Xu C, Macciardi F, Li PP, et al., 2006, Association of the
putative susceptibility gene, transient receptor potential disorder. Acta Biochim Pol, 53(2): 317–320.
protein melastatin Type 2, with bipolar disorder. Am J Med 121. McQuillin A, Bass NJ, Kalsi G, et al., 2006, Fine mapping

Volume 1 Issue 1 (2022) 17 https://doi.org/10.36922/an.v1i1.3